Author Correction: Functionally selective signaling and broad metabolic benefits by novel insulin receptor partial agonists.

Wu, Margaret; Carballo-Jane, Ester; Zhou, Haihong; Zafian, Peter; Dai, Ge; Liu, Mindy; Lao, Julie; Kelly, Terri; Shao, Dan; Gorski, Judith; Pissarnitski, Dmitri; Kekec, Ahmet; Chen, Ying; Previs, Stephen F; Scapin, Giovanna; Gomez-Llorente, Yacob; Hollingsworth, Scott A; Yan, Lin; Feng, Danqing; Huo, Pei; Walford, Geoffrey; Erion, Mark D; Kelley, David E; Lin, Songnian; Mu, James.

Afiliação

Wu M; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Carballo-Jane E; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Zhou H; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Zafian P; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Dai G; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Liu M; Merck & Co., Inc., South San Francisco, CA, 94080, USA.
Lao J; Merck & Co., Inc., South San Francisco, CA, 94080, USA.
Kelly T; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Shao D; Merck & Co., Inc., South San Francisco, CA, 94080, USA.
Gorski J; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Pissarnitski D; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Kekec A; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Chen Y; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Previs SF; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Scapin G; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Gomez-Llorente Y; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Hollingsworth SA; Merck & Co., Inc., South San Francisco, CA, 94080, USA.
Yan L; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Feng D; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Huo P; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Walford G; Merck & Co., Inc., Boston, MA, 02115, USA.
Erion MD; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Kelley DE; Merck & Co., Inc., Kenilworth, NJ, 07033, USA.
Lin S; Merck & Co., Inc., Kenilworth, NJ, 07033, USA. Songnian.lin@merck.com.
Mu J; Merck & Co., Inc., South San Francisco, CA, 94080, USA. yingjun_mu@merck.com.

Nat Commun ; 15(1): 688, 2024 Jan 23.

Article em En | MEDLINE | ID: mdl-38263326

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article